By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Substance Abuse Treatment market accounted for USD 2.4 billion in 2022 with a share of around 45.80%, and is expected to exhibit a significant CAGR growth during the study period. The growing population exposed to addiction, the legalization of marijuana in several states, well-structured reimbursement policies, and the developed healthcare sector with effective therapeutics for drug addiction are major factors attributed to the market growth in this region. These factors support the growth of the market in this region.
According to the U.S. Department of Health & Human Services, nearly a quarter of adults and adolescents reported binge drinking within the past month, and more than 27 million Americans have recently admitted to abusing prescription drugs or using illicit drugs. Alcohol abuse is estimated to have an annual economic cost of USD 249 billion, and illegal drug use has a yearly cost of USD 193 billion.
Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
News
At Rochester Institute of Technology, researchers from five colleges are experimenting with a novel method of providing aggressive behavior and alcohol/drug addiction sufferers with mental health therapy. In alliance with the Food and Drug Administration, RIT is conducting a randomized clinical trial to assess the efficacy of the "RITchCBT" therapy platform for treating individuals whose substance use disorders have resulted in intimate partner violence (IPV). The National Institutes of Health are backing the study. Depending on the achievement of milestones and NIH clearance to move on to the second phase of the award, total funding might exceed $4.8 million.
RITchCBT, a virtual environment created at RIT and configured to deliver cognitive behavioral treatment via an avatar, will be tested in the NIH clinical trial to determine its viability. The study will contrast human-led therapy sessions with the identical subject matter to RITchCBT.
Figure 3: SUBSTANCE ABUSE TREATMENT MARKET SHARE BY REGION 2023 (%)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Europe Substance Abuse Treatment market accounts for the second-largest market share. Alcohol and tobacco addiction affect a large portion of the population in European countries, which is a serious public health issue. With the aid of donations from individuals, businesses, and nonprofit organizations, numerous initiatives have been undertaken to support various awareness-raising activities. These actions encourage people to choose de-addiction therapies, fostering market expansion in this region.
According to the 2021 World Drug Report released by the United Nations Office on Drugs and Crime, over 275 million people used drugs in the previous year, and over 36 million people worldwide suffer from drug use disorders (UNODC). Moreover, the UK market of Substance Abuse Treatment held the largest market share, and the Germany market of Substance Abuse Treatment was the fastest-growing market in the region.
The Asia Pacific Substance Abuse Treatment Market is expected to grow at the fastest CAGR from 2022 to 2030. Some of the factors attributing to the market growth in this region include the increasing number of people dependent on alcohol, marijuana, cigarettes, cocaine, and other dangerous products. Additionally, the rise in drug awareness campaigns and associated preventive programmes is one of the major drivers of the market's expansion in this region. Further, the China market of Substance Abuse Treatment held the largest market share, and the India market of Substance Abuse Treatment was the fastest-growing market in the region.